论文部分内容阅读
我院自1982～1991年的十年间收治难治性心力衰竭88例,随机抽样44例用镁盐治疗,与同期44例无镁治疗做对照。兹将结果报告如下。资料和方法镁盐治疗组44例,简称用镁组。男28例,女16例,平均年龄48.5岁。其中心瓣膜病19例,非瓣膜病25例。非瓣膜病中肺心病9例,高血压性心脏病4例,冠心病6例,甲亢性心脏病1例,心肌病5例。心功能(NYHA)分级法Ⅳ级20例,Ⅲ级24例。伴频发性室早6例,室上速4例,快速性房颤2例,室速5例,AVBⅡ°、CRBBB、LHA 各2例。未用镁盐治疗组(对照组)44例,男26例,
88 cases of refractory heart failure were treated in our hospital from 1982 to 1991, 44 cases were randomly selected from magnesium salt treatment, compared with 44 cases without magnesium treatment during the same period. The result is reported below. Materials and Methods Magnesium salt treatment group of 44 cases, referred to as magnesium group. 28 males and 16 females, with an average age of 48.5 years. The central valve disease in 19 cases, 25 cases of non-valvular disease. Coronary heart disease in non-valvular disease in 9 cases, 4 cases of hypertensive heart disease, 6 cases of coronary heart disease, hyperthyroidism heart disease in 1 case, cardiomyopathy in 5 cases. Heart function (NYHA) grading Ⅳ method 20 cases, Ⅲ grade 24 cases. Six cases had frequent asymptomatic ventricular tachycardia, four cases had supraventricular tachycardia, two cases had rapid atrial fibrillation, five cases had ventricular tachycardia, and two had AVB Ⅱ °, CRBBB and LHA. Forty-four patients without magnesium salt treatment group (control group), 26 males,